← Open Payments lookup

DONNA KELLY: Open Payments

NPI 1730566647 · LAUGHLIN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$771 in 34 payments from 10 companies in 2025. Trend: 2023 $419 · 2024 $596 · 2025 $771

Food & beverage: $771
CompanyPaymentsAmount
Novo Nordisk Inc12$343
Verona Pharma, Inc.5$106
Dexcom, Inc.3$65
Bayer Healthcare Pharmaceuticals Inc.4$65
Lilly USA, LLC3$47
Amgen Inc.2$47
Xeris Pharmaceuticals, Inc.2$32
ABBVIE INC.1$27
Exact Sciences Corporation1$23
AstraZeneca Pharmaceuticals LP1$16

Products named: Rybelsus, Ozempic, Ohtuvayre, Dexcom G6 Transmitter, Kerendia, OTEZLA, JARDIANCE, GVOKE HYPOPEN.

Industry payments across NV — which companies pay providers there.